MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $494,450 | +24.5% | 11,351 | +3.2% | 0.00% | – |
Q2 2023 | $397,285 | -12.2% | 10,996 | -9.7% | 0.00% | – |
Q1 2023 | $452,555 | -20.0% | 12,172 | -2.5% | 0.00% | – |
Q4 2022 | $565,560 | -28.3% | 12,482 | +10.6% | 0.00% | -100.0% |
Q3 2022 | $789,000 | +9.0% | 11,290 | +4.6% | 0.00% | 0.0% |
Q2 2022 | $724,000 | -12.7% | 10,791 | +7.0% | 0.00% | 0.0% |
Q1 2022 | $829,000 | -45.9% | 10,088 | -3.4% | 0.00% | 0.0% |
Q4 2021 | $1,532,000 | -38.5% | 10,440 | -25.9% | 0.00% | -50.0% |
Q3 2021 | $2,491,000 | -3.2% | 14,083 | -11.6% | 0.00% | 0.0% |
Q2 2021 | $2,573,000 | -73.5% | 15,931 | -71.9% | 0.00% | -71.4% |
Q1 2021 | $9,720,000 | +84.6% | 56,743 | +136.7% | 0.01% | +75.0% |
Q4 2020 | $5,265,000 | +37.3% | 23,970 | +3.8% | 0.00% | +33.3% |
Q3 2020 | $3,835,000 | +41.7% | 23,094 | -2.6% | 0.00% | +50.0% |
Q2 2020 | $2,707,000 | +104.1% | 23,707 | +37.4% | 0.00% | +100.0% |
Q1 2020 | $1,326,000 | -30.9% | 17,248 | +15.9% | 0.00% | -50.0% |
Q4 2019 | $1,918,000 | +66.1% | 14,884 | +0.4% | 0.00% | +100.0% |
Q3 2019 | $1,155,000 | -19.7% | 14,832 | +6.1% | 0.00% | 0.0% |
Q2 2019 | $1,439,000 | +56.2% | 13,975 | +11.3% | 0.00% | 0.0% |
Q1 2019 | $921,000 | +336.5% | 12,559 | +180.8% | 0.00% | – |
Q3 2018 | $211,000 | +0.5% | 4,473 | +5.2% | 0.00% | – |
Q2 2018 | $210,000 | – | 4,251 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |